Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia
Eda Tanrikulu Simsek, Ahmet Emre Eskazan, Mahir Cengiz, Muhlis Cem Ar, Seda Ekizoglu, Ayse Salihoglu, Emine Gulturk, Tugrul Elverdi, Seniz Ongoren Aydin, Ahu Senem Demiroz, Ayse Nur Buyru, Zafer Baslar, Ugur Ozbek, Burhan Ferhanoglu, Yildiz Aydin, Nukhet Tuzuner, Teoman Soysal
Journal of Clinical Pathology Sep 2016, 69 (9) 810-816; DOI: 10.1136/jclinpath-2015-203320